Syndax Pharmaceuticals In... (SNDX)
NASDAQ: SNDX
· Real-Time Price · USD
15.71
0.98 (6.65%)
At close: Aug 15, 2025, 3:59 PM
16.00
1.88%
After-hours: Aug 15, 2025, 07:56 PM EDT
Syndax Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 37.96M | 20.04M | 7.68M | 12.5M | 3.5M | n/a | 536K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 126.58M | 12.38M | 379K | 379K |
Cost of Revenue | 1.28M | 885K | n/a | 2K | 44.34M | 3K | 268K | 3K | 152K | 113K | 115K | 108K | 110K | 121K | 121K | n/a | n/a | n/a |
Gross Profit | 36.68M | 19.16M | 6.85M | 12.5M | -40.84M | -3K | 268K | -3K | -152K | -113K | -115K | -108K | -110K | -121K | 126.45M | 12.38M | 379K | 379K |
Operating Income | -69.35M | -83.76M | -96.36M | -89.58M | -74.22M | -79.51M | -77.91M | -56.35M | -49.68M | -46.02M | -42.03M | -35.14M | -37.72M | -36.86M | 95.75M | -20.03M | -22.33M | -27.16M |
Interest Income | 5.95M | 7.18M | 7.11M | 5.44M | 6.28M | 7.26M | 5.55M | 5.34M | 5.19M | 5.08M | 2.99M | 1.78M | 878K | 224K | 91K | 83K | 108K | 120K |
Pretax Income | -71.85M | -84.85M | -94.17M | -84.13M | -68.06M | -72.4M | -72.47M | -51.15M | -44.62M | -41.13M | -39.19M | -35.4M | -37.57M | -37.17M | 96.2M | -20.64M | -22.91M | -27.72M |
Net Income | -71.85M | -84.85M | -94.17M | -84.13M | -68.06M | -72.4M | -72.47M | -51.15M | -44.62M | -36.19M | -36.31M | -35.66M | -37.57M | -37.48M | 96.2M | -20.64M | -22.91M | -27.72M |
Selling & General & Admin | 43.8M | 41.03M | 37.69M | 31.11M | 29.06M | 23.02M | 22.78M | 17.27M | 14.91M | 11.96M | 10.19M | 8.24M | 7.99M | 6.84M | 6.93M | 6.8M | 5.84M | 5.67M |
Research & Development | 62.23M | 61.64M | 65.53M | 70.97M | 48.65M | 56.49M | 55.13M | 39.09M | 34.76M | 34.05M | 31.84M | 26.9M | 29.73M | 30.02M | 23.9M | 25.61M | 16.87M | 21.87M |
Other Expenses | n/a | 247K | n/a | n/a | -86K | -87K | -55K | -66K | -93K | n/a | n/a | -295K | -31K | 116K | n/a | -41K | -50K | -57K |
Operating Expenses | 106.03M | 102.91M | 104.05M | 102.08M | 77.71M | 79.51M | 77.91M | 56.35M | 49.68M | 46.02M | 42.03M | 35.14M | 37.72M | 36.86M | 30.83M | 32.41M | 22.71M | 27.54M |
Interest Expense | 7.86M | -8.05M | 4.81M | 23K | 45K | 55K | 63K | 70K | 35K | 40K | 43K | 1.75M | 695K | 651K | n/a | 649K | 634K | 623K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -21.36M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 107.31M | 103.8M | 104.05M | 102.08M | 77.72M | 79.51M | 77.91M | 56.35M | 49.68M | 46.02M | 42.03M | 35.14M | 37.72M | 36.86M | 30.83M | 32.41M | 22.71M | 27.54M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | -40.28K | n/a | -3K | -58K | -4.93M | -2.88M | 262K | n/a | 311K | -10K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 86.34M | 85.62M | 85.79M | 85.43M | 85.27M | 85.21M | 72.52M | 69.86M | 69.64M | 69.44M | 63.19M | 60.67M | 60.16M | 58.98M | 51.79M | 51.96M | 51.6M | 51.5M |
Shares Outstanding (Diluted) | 86.34M | 85.62M | 85.79M | 85.43M | 85.27M | 85.21M | 72.52M | 69.86M | 69.64M | 69.44M | 63.19M | 60.67M | 60.16M | 58.98M | 53.18M | 51.96M | 51.6M | 51.5M |
EPS (Basic) | -0.83 | -0.99 | -1.1 | -0.98 | -0.8 | -0.85 | -1 | -0.73 | -0.64 | -0.52 | -0.57 | -0.59 | -0.62 | -0.64 | 1.81 | -0.4 | -0.44 | -0.54 |
EPS (Diluted) | -0.83 | -0.99 | -1.1 | -0.98 | -0.8 | -0.85 | -1 | -0.73 | -0.64 | -0.52 | -0.57 | -0.59 | -0.62 | -0.64 | 1.81 | -0.4 | -0.44 | -0.54 |
EBITDA | -63.99M | -83.76M | -89.36M | -84.1M | -68.02M | -72.34M | -72.41M | -51.07M | -44.43M | -40.97M | -39.04M | -33.55M | -36.77M | -36.4M | 96.32M | -19.98M | -22.27M | -27.08M |
EBIT | -63.99M | -92.89M | -89.36M | -84.1M | -68.02M | -72.34M | -72.41M | -51.08M | -44.58M | -41.09M | -39.15M | -33.66M | -36.88M | -36.52M | 96.2M | -19.99M | -22.28M | -27.1M |
Depreciation & Amortization | n/a | 9.14M | n/a | 2K | 3K | 3K | 3K | 3K | 152K | 113K | 115K | 108K | 110K | 121K | 121K | 113K | 105K | 117K |